News

Dr Paul MacLeman resigns

August 9, 2017

The Managing Director of IDT, Dr Paul MacLeman has resigned from the position, to advance new business initiatives and to pursue further non‐executive board roles. His resignation as CEO will take effect from 31st August 2017. Dr MacLeman will resign from the Board as at close of business today. The Chairman, Mr Graeme Kaufman, thanked…

Read More »

Dr Graeme Blackman AO retires

June 13, 2017

Australian pharmaceutical manufacturing and drug development company IDT Australia Limited (ASX: IDT) announces the retirement of our founder, Dr Graeme Blackman AO, from the Board.  Dr Blackman will remain an advisor to the Company.

Read More »

Manufacturing Hall of Fame Award

May 10, 2017

Australian pharmaceutical manufacturing and drug development company IDT Australia Limited has received a Victorian Manufacturing Hall of Fame award in the High Growth Sector of Medical Technologies and Pharmaceuticals. The award recognises outstanding achievements by Victorian businesses which uphold a high standard of excellence in Victorian manufacturing. IDT’s Boronia based facility specialises in the manufacturing…

Read More »